• 약학회지
• /
• 제39권6호
• /
• pp.636-644
• /
• 1995

Comparison of bioavailabflity (BA) of three brands of ranitidine (RT) tablets has been studied m rats. The purpose of this study was to characterize the pharniacolunetics of RT tablets in the rat and to coinpare phannacolunetic parameters of three brands of RT tablets. In addition, it was investigated whether plasma RT concentrations m humans can be predicted from pharmacokinetic parameters obtained in rats. RT was administered intravenously in dose of RT.HCI 10mg/kg and orally in dose of RT.HCI 50mg/kg as solution or crushed sample of thablets. Plasma RT concentrations were determned by HPLC. Plasma RT concentrations as a function of time were fitted to two compartment model. Plasma RT concentrations declined with a terminal half life ($t_{{1}/2{\betha}}$) of 40.9 min. The plasma RT concentration-time curve showed two peak plasma concentrations following an oral administration of solution or crushed sample in rats like humans. No significant difference among pharmacokinetic parameters was observed except $T_{max2}$ (p<0.05). The BA for crushed sample A, B and C were found to be 54.6 40.7 and 40.0%, respectively. Equivalence of $C_{max1}$ and $T_{max2}$ were guaranteed in this study. However, it was concluded that three brands of RT tablets are bioequivalent, taking the following characteristics of RT into consideration;(1) rapid onset of the effect is not required, (2) $C_{max1}$ and $T_{max2}$ do not seem to influence the effectiveness of the drug during a long-term treatment by the usual administration of twice a day. Results from this study were combined with plarmacokinetic data for RT in dogs and humans to develop a basis for interspecies scale-up of the disposition characteristics of the drug. there were similarities in the general disposition of the drug. Allometric relationships were sought between pharmacokinetic parameters nd species body weight. Significant interspecies correlations were found for total body clearance($Cl_{t}$) and steady state volume of distribution ($Bd_{ss}$). Thus, plasma RT concentrations in humans can be predicted from pharmacokinetic parameters obtained in rats.

• 한국패류학회지
• /
• 제23권1호
• /
• pp.17-23
• /
• 2007

2004년 10월부터 2005년 11월까지 전라북도 고창군 주진천에 서식하는 쇄방사늑조개의 서식지 환경과 성장을 조사하였다. 서식지의 월별 수온은 $4.6-29.3^{\circ}C$로 나타났으며, 1월에 가 장 낮았고, 8월에 가장 높았다. 지온은 $2.6-29.4^{\circ}C$로 나타났으며 수온과 비슷하게 1월과 2월에 낮았고 8월에 가장 높았다. 월별 염분은 2.3-20.2 psu로 평균 $8.21\;{\pm}\;4.77\;psu$였다. 쇄방사늑조개의 패각에 나타나는 윤문은 년 1회 형성되며, 주된 윤문 형성 시기는 10-12월임을 확연할 수 있었다. 초륜의 형성 기간은 약 5개월 (0.42년) 으로 나타났으며, 각장 (SL) 과 각고 (SH) 간의 관계는 SH = 0.4352 SL + 0.5642 ($R^2\;=\;0.978$) 이고, 각장과 각폭 (SW) 간의 관계는 SW = 0.4352 SL - 0.5675 ($R^2\;=\;0.957$) 이며, 각장과 전중량 (TW) 간의 관계는 $TW\;=\;6.999\;{\times}\;10^{-5}\;SL^{3.2542}\;(R^2\;=\;0.975)$ 로 나타났다. 연령 (t) 에 대한 각장 (SL) 의 Bertalanffy 성장식은 $SL_t\;=\;30.77\;[1-e^{-0.4572(t+0.7371)}]$였으며, 전중량 (TW) 의 Bertalanffy 성장식은 $TW_t\;=\;4.87\;[1-e^{-0.4572(t+0.7371)}]^{3.2542}$로 추정되었다.

• 대한기계학회논문집
• /
• 제18권9호
• /
• pp.2331-2338
• /
• 1994

Experimental conditions of the optical shadow methods of caustics for measurement of the stress intensity factor and the J-integral in various materials(polycarbonate, PMMA, Al 5586D) are investigated. The necessary experimental requirements toe determine accurate values of the stress intensity factors and the J-integrals are described. The ratio of $r_o$ (radius of initial curve) to $r_p$ (plastic zone size) is selected as a parameter to verify the experimental limitation of the method of caustics in determination of fracture parameters. In this study, transmission caustics method was used for compact tension specimens made of polycarbonate and PMMA. while reflection caustics method was applied to c-shaped tension specimen made of Al 5586D. The appropriate ranges of $r_o/r_p$ tp determine accurate values of stress intensity factors were found to be 1.5~1.8. Existing experimental results have been obtained mainly by changing $r_p$ with different loads in $r_o/r_p$. However, in this study we could obtain varying $K_{caus}/K_{th}$ over the wide range of $r_o/r_p$ at fixed load conditions with newly designed optical arrangement. Thus, we could find the range in which theoretical and experimental results agree well each other by changing $r_o$ values only. In Al 5586D specimen, experimental caustics were located inside of the plastic zone, and $K_{caus}/K_{th}$ were found to be not unity in this range. It is found that $J_{caus}/J_{th}=1{\;}with{\;}r_o/t{\geq}0.8$ and the experimental plastic zone includes the contours of caustics.

• 한국세라믹학회지
• /
• 제22권3호
• /
• pp.35-40
• /
• 1985

The composition of the base glass was determined to be $Na_2O$ 15, $Fe_2O_3$ 35, $B_2O_3$ 0~20, $P_2O_5$ 30~50 by mole percent. The heating temperature for nucleation was determined by means of thermal expansion curve. Crystalline phases were investigated by X-ray diffraction method and I.R Spectra. Electrical conductivities of glass spec-imens were observed in the temperature range 25~20$0^{\circ}C$ The activation energies of these specimens were caculated. The results obtained were as follows : 1) The limit composition of the melts 15mol% $Na_2O$ 35mole% $Fe_2O_5$ 20mole% $B_2O_3$ 30mole% $P_2O_5$ was able to be formed into desired shapes during cooling, . 2) In the measurement of d. c conductivity($\delta$) on the glasses in the system $15Na_2O-35Fe_2O_3$-$B_2O_3$-(50-x) $P_2O_5$ the values decreased by replacing 5 mole% $P_2O_5$ with $B_2O_3$ 3) The d. c conducties of heat treated samples were increased by replacing $P_2O_5$ with $B_2O_3$ 4) $B_2O_3$ contributed to precipitate crystals such as${\gamma}$-$Fe_2O_3$ $Fe_3O_4$ which had the advantage of electronic conduction in heat treated samples. 5) The slope plotted Log($\delta$) versus 1/T in this glass system was linear in the measured temperature range.

• Journal of Pharmaceutical Investigation
• /
• 제35권2호
• /
• pp.101-106
• /
• 2005

The pharmacokinetics of oral nifedipine (5 mg/kg) was studied in rabbits given after or simultaneously with naringin (1.5, 7.5 and 15 mg/kg, respectively). The area under the plasma concentration-time curve (AUC) and the peak concentration $(C_{max})$ of nifedipine coadministered or pretreated with naringin were significantly increased (p < 0.05, coad.; p < 0.01, pret.) compared with the control group. The absolute bioavailability (AB%) of nifedipine was significantly (p < 0.05, coad.; p < 0.01, pret.) higher by 22.3 - 28.1 % compared to the control (17.9%). The relative bioavailability (RB%) of nifedipine was higher by 1.24 - 1.43 times (coad.) and 1.32 -1.57 times (pret.) than those of the control, showing that preatreatrnent of naringin was more effective than that of the coadministration of naringin. Naringin did not show significant effect on the Tmax and $t_{1/2}$ of nifedipine. It is suggested that naringin may alter pharmacokinetic paramiters of nifedipine by inhibition of P-glycoprotein efflux pump and its first-pass metabolism. The dosage of nifedipine should be adjusted when it is administered with naringin in a clinical situation.

• 한국임상약학회지
• /
• 제18권1호
• /
• pp.6-10
• /
• 2008

This study investigated the effect of long-term administration of pioglitazone on the pharmacokinetics of verapamil in rats. Pharmacokinetic parameters of verapamil were determined after oral administration of verapamil (9 mg/kg) in rats coadministered pioglitazone (0.5 mg/kg) or pretreated with pioglitazone (0.5 mg/kg) for 3 and 9 days. Compared to oral control group, the presence of pioglitazone significantly (p<0.05) increased the area under the plasma concentration-time curve (AUC) of verapamil by 48.6% (coad), 61.1% (3 days) and 56.5% (9 days), and the peak concentration($C_{max}$) by 65.1% (coad), 76.8% (3 days) and 66.4% (9 days). The absolute bioavailability (AB%) of verapamil was significantly (p<0.05) higher by 6.2% (coad), 6.7% (3 days), 6.5% (9 days) compared to control (4.2%), and presence of pioglitazone was no significant change in the terminal half-life ($t_{1/2}$) and the time to reach the peak concentration($T_{max}$) of verapamil. Our results indicate that pioglitazone significantly enhanced oral bioavailability of verapamil in rats, implying that presence of pioglitazone could be effective to inhibit the CYP3A4-mediated metabolism of verapamil in the intestine. Drug interactions should be considered in the clinical setting when verapamil is coadministrated with pioglitazone.

• Archives of Pharmacal Research
• /
• 제17권2호
• /
• pp.80-86
• /
• 1994

The bioavailability of digoxin generic tablets manufactures in Korea (formulations A & B) wwere compared to a standard (formulation C; Lanoxin brand digoxin, Burroughs Wellcome, USA) in 12 healthy Korean male volunteers (mean age 31.4 years) in a single dose, randomized, complete block crossover study. Using a latin square design, each of the subjects was randomized to the order number and allocated to each of the three treatments of 0.5mg oral digoxin. Digoxin conc4ntrations in serum and urine samples collected for 48 hours after dosing were measured by fluoprescence polarization immunoassy and radioimmunoassy, respectively. Treatments were compared by using nonlinear least squares regession analysis to evaluate the following pharmacokinetic parameters : maximum serum concentation $(C_{max})$; time of maximum serum concentation $(T_{max})$; area under the serum concentration-time curve $AUC_{0-12}$, $C_{max}$\;and\;(AUC_{0-12})$; and cummulative urinary excretion for 0-48 hours $(CLE_{0-48}.\;Mean\;AUC_{0-12},\;C_{max},\;and\;CUE_{0-48}$ values for formulations B and C were significantly different from formulation A (P<0.001), but not significantly diffeerent form each other. Basede on $AUL_{0-12}\;and\;CUE_{0-48}$ respectively, the relative availability of formulation B was 87.5% and 89.6% and the relative availability of formultation A was 43% and 35% when compared to formulation C(the standard).

• 대한지역사회영양학회지
• /
• 제19권5호
• /
• pp.490-498
• /
• 2014

Objectives: This study was conducted to propose the need of re-establishing the criteria of the body weight classification in the elderly. We compared the Asia-Pacific Region Criteria (APR-C) with Entropy Model Criteria (ENT-C) using Morbidity rate of chronic diseases which correlates significantly with Body Mass Index (BMI). Methods: Subjects were 886 elderly female participating in the 2007-2009 Korea National Health and Nutrition Examination Survey (KNHANES). We compared APR-C with those of ENT-C using Receiver Operating Characteristics (ROC) curve and logistic regression analysis. Results: In the case of the morbidity of hypertension, the results were as follows: Where it was in the T-off point of APR-C, sensitivity was 67.5%, specificity was 43.1%, and Youden's index was 10.6. While in the cut-off point of ENT-C, it was 56.7%, 56.6%, and 13.3 respectively. In the case of the morbidity of diabetes, the results were as follows: In the cut-off point of APR-C, Youden's index was 14.2. While in the cut-off point of ENT-C, it was 17.2 respectively. The Area Under the ROC Curve (AUC) of the subjects who had more than 2 diseases among hypertension, diabetes, and dyslipidemia was 0.615 (95% CI: 0.578-0.652). Compared to the normal group, the odds ratio of the hypertension group which will belong to the overweight or obesity was 1.79 (95% CI: 1.30-2.47) in the APR-C, and 2.04 (95% CI: 1.49-2.80) in the ENT-C (p < 0.001). Conclusions: We conclude that the optimal cut-off point of BMI to distinguish between normal weight and overweight was $24kg/m^2$ (ENT-C) rather than $23kg/m^2$ (APR-C).

• 터널과지하공간
• /
• 제21권6호
• /
• pp.460-470
• /
• 2011

자연환경하에 있는 암석의 풍화특성과 풍화된 암석의 강도평가를 위하여 다양한 크기의 아소 가족묘비석을 대상으로 탄성파 속도를 측정하였다. 그 결과 크기가 다른 시료를 동일한 크기로 환산하여 탄성파 속도를 평가하는 크기 보정법과 새로운 암석 풍화지표로서 NET(Normalized Elapsed Time)를 제안하였다. 또한 NET을 이용한 암석 풍화 분류로부터 풍화암석에 대한 강도를 추정하였다. 용결응회암의 경우 탄성파 속도는 높고 속도저하는 거의 나타나지 않았지만, 안산암의 경우 탄성파 속도는 낮고 속도저하 현상이 관찰되었다. $V_p/V_o$-NET 곡선에 근거한 NET를 이용할 경우 크기가 다른 다양한 암석에 대해 같은 크기로 풍화정도를 비교할 수 있을 것으로 판단된다. 또한 $S_c/S_o$-NET 곡선에 의한 NET을 이용하여 암석의 풍화단계 분류가 가능하였으며, 이것으로부터 풍화 암석에 대한 강도추정도 가능하였다.

• 약학회지
• /
• 제54권4호
• /
• pp.252-257
• /
• 2010

The aim of this study was to investigate the effect of resveratrol on the pharmacokinetics of nifedipine in rats. The pharmacokinetic parameters of nifedipine were measured after the oral administration of nifenipine (6 mg/kg) in the presence or absence of resveratrol (0.5, 2.5 and 10 mg/kg, respectively). The effect of resveratrol on the P-glycoprotein (Pgp), CYP 3A4 activity was also evaluated. Resveratrol inhibited CYP3A4 enzyme activity in a concentration-dependent manner with 50% inhibition concentration ($IC_{50}$) of 0.94 ${\mu}M$. In addition, resveratrol significantly enhanced the cellular accumulation of rhodamine 123 in MCF-7/ADR cells overexpressing P-gp. Compared to the control groups, the presence of 2.5 mg/kg and 10 mg/kg of resveratrol significantly (p<0.05, p<0.01) increased the area under the plasma concentrationtime curve (AUC) of nifedipine by 49~75%, and the peak concentration ($C_{max}$) of nifedipine by 48~66%. The absolute bioavailability (AB%) of nifedipine was significantly (p<0.05) increased by 22.9-34.8% compared to the control (19.8%). The terminal half-life ($T_{1/2}$) of nifedipine was significantly (p<0.05) increased compared to the control. While there was no significant change in the time to reach the peak plasma concentration ($T_{max}$) of nifedipine in the presence of resveratrol. It might be suggested that resveratrol altered disposition of nifedipine by inhibition of both the CYP3A and P-glycoprotein efflux pump in the small intestine of rats. In conclusion, the presence of resveratrol significantly enhanced the oral bioavailability of nifedipine, suggesting that concurrent use of resveratrol or resveratrol-containing dietary supplenment with nifedipine should require close monitoring for potential drug interation.